• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Peripheral artery disease (PAD) imposes a heavy burden of major adverse cardiovascular
events that are associated with considerable mortality and morbidity, and major adverse …

Purpose Patients with polyvascular disease (PVD) are at very high cardiovascular risk and
require intensive lipid-lowering therapy. This analysis describes the lipid-lowering efficacy …

1.1. Purpose The European Society for Vascular Surgery (ESVS) has developed a series of
clinical practice guidelines for clinicians caring for patients with vascular diseases. This is …

Aims Patients with coronary and peripheral artery disease (PAD) have a residual risk of
major adverse cardiovascular and limb events despite standards of care. Among patients …

Objective The long-term predictive performance of existing bleeding risk models in patients
with various manifestations of cardiovascular disease (CVD) is not well known. This study …

Peripheral artery disease (PAD) is the occlusion or narrowing of the arteries supplying the
lower extremities. Peripheral artery disease has been estimated to affect approximately 240 …

The recent shift of the concept of cardiovascular disease as a chronic progressive condition,
potentially involving multiple districts, has driven attention to the optimal management of …

Introduction/Objective Carotid stenosis (CS) is an important cause of ischemic stroke.
Secondary prevention lies in performing a carotid endarterectomy (CEA) procedure, the …

Objective Adenosine diphosphate (ADP) receptor inhibitors such as clopidogrel are known
to be less effective at reducing platelet function for some patients because of a phenomenon …